Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2018, Article ID 3968015, 8 pages
https://doi.org/10.1155/2018/3968015
Research Article

Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia

1Institute of Mental Health, University of Nottingham, Nottingham, UK
2Nottinghamshire Healthcare NHS Foundation Trust, Nottinghamshire, UK
3Mahatma Gandhi Medical College and Research Institute, Pondicherry, India
4K S Mani Centre for Cognitive Neurosciences, Central Institute of Psychiatry, Ranchi, India

Correspondence should be addressed to Mohammad Zia Ul Haq Katshu; moc.liamg@qahluaizrd

Received 7 August 2017; Accepted 17 January 2018; Published 20 February 2018

Academic Editor: Nakao Iwata

Copyright © 2018 Mohammad Zia Ul Haq Katshu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Cohrs, “Sleep disturbances in patients with schizophrenia: impact and effect of antipsychotics,” CNS Drugs, vol. 22, no. 11, pp. 939–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Chouinard, J. Poulin, E. Stip, and R. Godbout, “Sleep in untreated patients with schizophrenia: A meta-analysis,” Schizophrenia Bulletin, vol. 30, no. 4, pp. 957–967, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Monti and D. Monti, “Sleep in schizophrenia patients and the effects of antipsychotic drugs,” Sleep Medicine Reviews, vol. 8, no. 2, pp. 133–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Sarkar, M. Z. U. H. Katshu, S. H. Nizamie, and S. K. Praharaj, “Slow wave sleep deficits as a trait marker in patients with schizophrenia,” Schizophrenia Research, vol. 124, no. 1-3, pp. 127–133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Maixner, R. Tandon, A. Eiser, S. Taylor, J. R. DeQuardo, and J. Shipley, “Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: A replication and extension,” The American Journal of Psychiatry, vol. 155, no. 11, pp. 1600–1602, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Yamashita, S. Morinobu, S. Yamawaki, J. Horiguchi, and M. Nagao, “Effect of risperidone on sleep in schizophrenia: A comparison with haloperidol,” Psychiatry Research, vol. 109, no. 2, pp. 137–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Hinze-Selch, J. Mullington, A. Orth, C. J. Lauer, and T. Pollmächer, “Effects of clozapine on sleep: a longitudinal study,” Biological Psychiatry, vol. 42, no. 4, pp. 260–266, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. L. Sharpley, C. M. Vassallo, and P. J. Cowen, “Olanzapine increases slow-wave sleep: Evidence for blockade of central 5-HT(2C) receptors in vivo,” Biological Psychiatry, vol. 47, no. 5, pp. 468–470, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. Sharpley, C. M. Vassallo, E. C. Pooley, P. J. Harrison, and P. J. Cowen, “Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine,” Psychopharmacology, vol. 153, no. 2, pp. 271-272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Lindberg, M. Virkkunen, P. Tani et al., “Effect of a single-dose of olanzapine on sleep in healthy females and males,” International Clinical Psychopharmacology, vol. 17, no. 4, pp. 177–184, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Giménez, S. Clos, S. Romero, E. Grasa, A. Morte, and M. J. Barbanoj, “Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers,” Psychopharmacology, vol. 190, no. 4, pp. 507–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Sharpley, M. E. J. Attenburrow, S. Hafizi, and P. J. Cowen, “Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients,” Journal of Clinical Psychiatry, vol. 66, no. 4, pp. 450–454, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Salin-Pascual, M. Herrera-Estrella, L. Galicia-Polo, and M. R. Laurrabaquio, “Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency,” Biological Psychiatry, vol. 46, no. 1, pp. 141–143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. R. J. Salin-Pascual, M. Herrera-Estrella, L. Galicia-Polo, M. Rosas, and E. Brunner, “Low delta sleep predicted good clinical response to olanzapine administration in schizophrenia patients,” Revista de investigación clínica; Organo del Hospital de Enfermedades de la Nutrición, vol. 56, pp. 345–350, 2004. View at Google Scholar
  15. M. J. Müller, W. Rossbach, K. Mann et al., “Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms,” Pharmacopsychiatry, vol. 37, no. 4, pp. 157–162, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Tandon, J. E. Shipley, S. Taylor et al., “Electroencephalographic Sleep Abnormalities in Schizophrenia: Relationship to Positive/Negative Symptoms and Prior Neuroleptic Treatment,” Archives of General Psychiatry, vol. 49, no. 3, pp. 185–194, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Göder, G. Fritzer, B. Gottwald et al., “Effects of olanzapine on slow wave sleep, sleep spindles and sleep-related memory consolidation in schizophrenia,” Pharmacopsychiatry, vol. 41, no. 3, pp. 92–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kluge, A. Schacht, H. Himmerich et al., “Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature,” Schizophrenia Research, vol. 152, no. 1, pp. 255–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research, World Health Organization, Geneva, Switzerland, 1993.
  20. A. B. Douglass, R. Bornstein, G. Nino-Murcia et al., “The Sleep Disorders Questionnaire I: Creation and multivariate structure of SDQ,” SLEEP, vol. 17, no. 2, pp. 160–167, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. K. Mandai, G. Pandey, S. K. Singh, and H. S. Asthana, “Hand Preference in India,” International Journal of Psychology, vol. 27, no. 6, pp. 433–442, 1992. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Addington, J. Addington, and B. Schissel, “A depression rating scale for schizophrenics,” Schizophrenia Research, vol. 3, no. 4, pp. 247–251, 1990. View at Publisher · View at Google Scholar · View at Scopus
  23. J. E. Overall and D. R. Gorham, “The Brief Psychiatric Rating Scale (BPRS),” Psychological Reports, vol. 24, pp. 97–99, 1962. View at Google Scholar
  24. S. R. Kay, A. Fiszbein, and L. A. Opler, “The positive and negative syndrome scale (PANSS) for schizophrenia,” Schizophrenia Bulletin, vol. 13, no. 2, pp. 261–276, 1987. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Lingjaerde, U. G. Ahlfors, P. Bech, S. J. Dencker, and K. Elgen, “The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients,” Acta Psychiatrica Scandinavica, Supplement, vol. 334, pp. 1–100, 1987. View at Google Scholar · View at Scopus
  26. A. Rechtschaffen and A. Kales, A Manual of Standardized Terminology, Techniques and Scoring Systems of Human Subjects, UCLA Information Service, Brain Research Institute, Los Angeles, Calif, USA, 1968.
  27. American Academy of Sleep Medicine, International Classification of Sleep Disorders - Diagnostic and Coding Manual, 2nd edition, 2005.
  28. W. P. Dunlap, J. M. Cortina, J. B. Vaslow, and M. J. Burke, “Meta-analysis of experiments with matched groups or repeated measures designs,” Psychological Methods, vol. 1, no. 2, pp. 170–177, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. M. S. Keshavan, C. F. Reynolds, J. Miewald, and D. Montrose, “Slow‐wave sleep deficits and outcome in schizophrenia and schizoaffective disorder,” Acta Psychiatrica Scandinavica, vol. 91, no. 5, pp. 289–292, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Goldman, R. Tandon, J. R. DeQuardo, S. F. Taylor, J. Goodson, and M. McGrath, “Biological predictors of 1-year outcome in schizophrenia in males and females,” Schizophrenia Research, vol. 21, no. 2, pp. 65–73, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Modell, M. Ising, F. Holsboer, and C. J. Lauer, “The Munich vulnerability study on affective disorders: Premorbid polysomnographic profile of affected high-risk probands,” Biological Psychiatry, vol. 58, no. 9, pp. 694–699, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Tandon and W. Wolfgang Fleischhacker, “Comparative efficacy of antipsychotics in the treatment of schizophrenia: A critical assessment,” Schizophrenia Research, vol. 79, no. 2-3, pp. 145–155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. A. Solomon, A. L. Sharpley, and P. J. Cowen, “Increased slow wave sleep with 5-HT2 receptor antagonists: Detection by ambulatory EEG recording and automatic sleep stage analysis,” Journal of Psychopharmacology, vol. 3, no. 3, pp. 125–129, 1989. View at Publisher · View at Google Scholar · View at Scopus
  34. F. P. Bymaster, D. O. Calligaro, J. F. Falcone et al., “Radioreceptor binding profile of the atypical antipsychotic olanzapine,” Neuropsychopharmacology, vol. 14, no. 2, pp. 87–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. A. L. Sharpley, A. E. S. Walsh, and P. J. Cowen, “Effect of nefazodone and lithium on sleep architecture in healthy men,” Journal of Psychopharmacology, vol. 10, no. 1, pp. 26–29, 1996. View at Google Scholar · View at Scopus
  36. A. L. Sharpley, J. M. Elliott, M.-J. Attenburrow, and P. J. Cowen, “Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors,” Neuropharmacology, vol. 33, no. 3-4, pp. 467–471, 1994. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Tesolin-Decros, C. Sebban, J. Ciprian-Ollivier, and L. Perret, “Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, α1- and 5-HT2A-receptors,” British Journal of Pharmacology, vol. 135, no. 1, pp. 65–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. M. I. Smith, D. C. Piper, M. S. Duxon, and N. Upton, “Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: A comparison to paroxetine,” Pharmacology Biochemistry & Behavior, vol. 71, no. 4, pp. 599–605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Monti, G. Pineyro, C. Orellana et al., “5-HT receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 8-OH-DPAT increase wakefulness in the rat,” Biogenic Amines, vol. 7, no. 2, pp. 145–151, 1990. View at Google Scholar · View at Scopus
  40. S. Kantor, R. Jakus, B. Balogh, A. Benko, and G. Bagdy, “Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT 2B receptor by the subtype-selective antagonist SB-215505,” British Journal of Pharmacology, vol. 142, no. 8, pp. 1332–1342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Riemann, F. Hohagen, S. Krieger et al., “Cholinergic REM induction test: Muscarinic supersensitivity underlies polysomnographic findings in both depression and Schizophrenia,” Journal of Psychiatric Research, vol. 28, no. 3, pp. 195–210, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Tokunaga, Y. Takeda, K. Shinomiya, M. Hirase, and C. Kamei, “Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats,” Journal of Pharmacological Sciences, vol. 103, no. 2, pp. 201–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M.-F. Wu and J. M. Siegel, “Facilitation of the acoustic startle reflex by ponto-geniculo-occipital waves: effects of PCPA,” Brain Research, vol. 532, no. 1-2, pp. 237–241, 1990. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Siegel, “Brainstem Mechanisms Generating REM Sleep,” in Principles and Practice of Sleep Medicine, Medicine., M. H. Kryger, T. Roth, and W. C. Dement, Eds., pp. 112–133, WB Saunders, Philadelphia, Penn, USA, 3rd edition, 2000. View at Google Scholar
  45. M. S. Keshavan, V. A. Diwadkar, D. M. Montrose, J. A. Stanley, and J. W. Pettegrew, “Premorbid characterization in schizophrenia: the Pittsburgh High Risk Study,” World Psychiatry, vol. 3, pp. 163–168, 2004. View at Google Scholar
  46. K. L. Benson and V. P. Zarcone Jr., “Testing the REM sleep phasic event intrusion hypothesis of schizophrenia,” Psychiatry Research, vol. 15, no. 3, pp. 163–173, 1985. View at Publisher · View at Google Scholar · View at Scopus
  47. J. F. Hiatt, T. C. Floyd, P. H. Katz, and I. Feinberg, “Further Evidence of Abnormal Non-Rapid-Eye-Movement Sleep in Schizophrenia,” Archives of General Psychiatry, vol. 42, no. 8, pp. 797–802, 1985. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Crespo-Facorro, J. M. Pelayo-Terán, R. Pérez-Iglesias et al., “Predictors of acute treatment response in patients with a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables,” Journal of Psychiatric Research, vol. 41, no. 8, pp. 659–666, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. K. L. Benson, E. V. Sullivan, K. O. Lim, J. Lauriello, V. P. Zarcone Jr., and A. Pfefferbaum, “Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia,” Psychiatry Research, vol. 60, no. 2-3, pp. 125–134, 1996. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Molina, J. Sanz, C. Benito, and T. Palomo, “Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia,” International Clinical Psychopharmacology, vol. 19, no. 4, pp. 221–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Milev, B.-C. Ho, S. Arndt, P. Nopoulos, and N. C. Andreasen, “Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: A prospective longitudinal study with 5-year follow-up,” Biological Psychiatry, vol. 54, no. 6, pp. 608–615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Gasquet, J. M. Haro, D. Novick, E. T. Edgell, L. Kennedy, and J. P. Lepine, “Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: Results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study,” International Clinical Psychopharmacology, vol. 20, no. 4, pp. 199–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. V. S. Rotenberg, J. Hadjez, T. Martin et al., “First night effect in different forms of Schizophrenia (Pilot investigation),” Dynamic Psychiatry, vol. 172/173, pp. 421–430, 1998. View at Google Scholar
  54. M. Jobert, F. J. Wilson, T. Roth et al., “Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG),” Neuropsychobiology, vol. 67, pp. 127–167, 2013. View at Google Scholar